Family is at the heart of our community.

UNITED FOR HD

At the Huntington Society of Canada, your support drives vital research, empowers advocacy, and ensures compassionate care. Together, we’re improving quality of life today while building hope for a future free of Huntington disease (HD).

Huntington Society of Canada

HD Information

Huntington disease is a genetic neurodegenerative disorder.
Huntington Society of Canada

HD Support

The Family Services team offers care and direct support.

Huntington Society of Canada

Research

Learn how we fund and support Huntington disease research.

Huntington Society of Canada

Get Involved

Join events, volunteer, or raise awareness for HD today.

You make progress possible.

Please select the type of donation you’d like to make and help support families impacted by Huntington disease.

Other Ways to Give

Join an Event

Volunteer

Raise Awareness

Upcoming Community Events

Niagara Chapter’s Quilt Raffle

Sunday, November 1, 2026
- Monday, November 30, 2026

Latest News

Clinical Research

uniQure announces FDA acceptance and Priority Review of ifezuntirgene inilparvovec BLA and confirmatory study

The U.S. FDA has accepted uniQure’s application for ifezuntirgene inilparvovec (AMT-130), an investigational gene therapy for Huntington disease, and granted it Priority Review. The FDA’s target decision date is May 1, 2027, although this is not a guarantee of a decision or approval. The therapy is not yet approved. UniQure and the FDA have also aligned on key elements of a confirmatory study that expects to enroll 200 participants for a minimum 3-year long study. International study sites are expected to be announced in the first half of 2027.
Monday, November 2, 2026

Clinical Research

Alnylam announces positive initial Phase 1b Data for brezosiran (ALN-HTT02)

Alnylam announces positive initial Phase 1b Data for brezosiran (ALN-HTT02), demonstrating deep and durable huntingtin lowering in Huntington disease, and plans to begin a larger, placebo-controlled efficacy study in 2027, pending alignment with regulators.
Wednesday, October 28, 2026

Sign up for our emails

Please fill in the fields below and then click the submit button.

Newsletter Sign-Up
By submitting this form, you are granting HSC permission to email you.

You may unsubscribe via the link found at the bottom of every email.